ERK/MAPK activation involves hypoxia‐induced MGr1‐Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer
Open Access
- 8 December 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 127 (4) , 820-829
Abstract
We previously demonstrated that hypoxia increased the hypoxia‐inducible factor (HIF‐1)–dependent MGr1‐Ag/37LRP expression, which enhanced adhesion of gastric cancer cells to laminin, inhibited drug‐induced apoptosis and caused cell adhesion–mediated drug resistance (CAM‐DR). Here, we investigated the role of extracellular‐regulated kinase (ERK) 1/2 in the signaling mechanisms underlying these events. We found that hypoxia activated ERK activityin vitroandin vivo. Overexpression of mitogen‐activated protein kinase (MAPK) kinase (MEK), which preferentially activated ERK, mimics, in a nonadditive way, hypoxia‐induced activity ofMGr1‐Ag/37LRPpromoter and expression of MGr1‐Ag/37LRP. Furthermore, U0126, the MEK inhibitor, inhibited hypoxia‐ and MEK‐inducedMGr1‐Ag/37LRPpromoter activity in a dose‐dependent manner. MEK inhibition also reversed hypoxia‐ and MEK‐induced HIF‐1 protein and its activity in a dose‐dependent manner. We also investigated reactive oxygen species signaling this response. Exogenous addition of H2O2was sufficient to activate ERK in a dose‐dependent profile. Reactive oxygen species scavengers of H2O2significantly inhibited hypoxia‐induced ERK or HIF‐1 activation and sequential expression of MGr1‐Ag/37LRP. We also investigated the signaling in hypoxia‐induced cell adhesion and apoptosis induced by vincristine. Hypoxia significantly enhanced adhesion of SGC7901 cells to laminin in a time‐dependent manner, which might be inhibited by the MEK inhibitor U0126 and MGr1‐Ag/37LRP siRNA. Consistent with results of adhesion assay, hypoxia‐resistant apoptosis might be reversed by U0126 in a dose‐dependent manner. Our results suggest that hypoxia‐elicited MGr1‐Ag/37LRP expression activated by HIF‐1 depends on ERK activation. These events are dependent of reactive oxygen intermediates.Keywords
This publication has 37 references indexed in Scilit:
- Reactive oxygen species mediates disialoganglioside GD3‐induced inhibition of ERK1/2 and matrix metalloproteinase‐9 expression in vascular smooth muscle cellsThe FASEB Journal, 2006
- Regulation of the mitogen-activated protein kinase p44 ERK activity during anoxia/recovery in rainbow trout hypodermal fibroblastsJournal of Experimental Biology, 2006
- Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexateBiochemical and Biophysical Research Communications, 2006
- Is the hypoxia-inducible factor pathway important in gastric cancer?European Journal of Cancer, 2005
- Hypoxia Activates MAPK Activity in Rat Nucleus Pulposus CellsSpine, 2005
- c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor 1α–Dependent P-Glycoprotein Expression in HypoxiaCancer Research, 2004
- Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4Experimental & Molecular Medicine, 2004
- MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cellsGastric Cancer, 2002
- Hypoxia activates β1-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002